VCAM1 and Hepatic fibrosis: Interestingly, with development of bridging fibrosis at week 52, changes in pathways related to hepatic fibrosis/hepatic stellate cells activation decreased as compared to 24 weeks and were mainly limited to increase in genes for Col4a1, Mmp12, Mmp13 and Vcam1 (Fig. 5).